CSIMarket
 


Baxter International Inc   (NYSE: BAX)
Other Ticker:  
 
 

BAX's Revenue Growth by Quarter and Year

Baxter International Inc 's Revenue results by quarter and year

 



BAX Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December - 533.00 3,749.00 3,887.00
3rd Quarter September - 2,699.00 3,708.00 3,773.00
2nd Quarter June - 3,812.00 3,707.00 3,746.00
1st Quarter March 2,625.00 3,592.00 3,649.00 3,707.00
FY   2,625.00 10,636.00 14,813.00 15,113.00

BAXs Annual Revenue
Baxter International Inc 's Revenue in the fiscal year 2024 $ 10,636.00 millions
Baxter International Inc 's Revenue in the fiscal year 2023 $ 14,813.00 millions
Baxter International Inc 's Revenue in the fiscal year 2022 $ 15,113.00 millions
Baxter International Inc 's Revenue in the fiscal year 2021 $ 12,784.00 millions
Baxter International Inc 's Revenue in the fiscal year 2020 $ 11,673.00 millions




BAX Revenue first quarter 2025 Y/Y Growth Comment
Baxter International Inc reported fall in Revenue in the first quarter 2025 by -26.92% to $ 2,625.00 millions, from the same quarter in 2024.
The drop in the first quarter 2025 Baxter International Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 4.83%.

Looking into first quarter 2025 results within Medical Equipment & Supplies industry 83 other companies have achieved higher Revenue growth. While Baxter International Inc ' s Revenue drop of -26.92% ranks overall at the positon no. 1746 in the first quarter 2025.




BAX Revenue ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter December - -85.78 % -3.55 % 10.61 %
3rd Quarter September - -27.21 % -1.72 % 16.96 %
2nd Quarter June - 2.83 % -1.04 % 20.92 %
1st Quarter March -26.92 % -1.56 % -1.56 % 25.83 %
FY   - -28.2 % -1.99 % 18.22 %

Financial Statements
Baxter International Inc 's first quarter 2025 Revenue $ 2,625.00 millions BAX's Income Statement
Baxter International Inc 's first quarter 2024 Revenue $ 3,592.00 millions Quarterly BAX's Income Statement


BAX Revenue (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter December - -80.25 % 1.11 % 3.02 %
3rd Quarter September - -29.2 % 0.03 % 0.72 %
2nd Quarter June - 6.12 % 1.59 % 1.05 %
1st Quarter March 392.5 % -4.19 % -6.12 % 5.49 %
FY (Year on Year)   - -28.2 % -1.99 % 18.22 %




Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #84
Healthcare Sector #279
Overall #1746

Revenue Y/Y Growth Statistics
High Average Low
87.04 % 4.83 % -55.46 %
(March 31, 2014)   (June 30. 2016)
Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #84
Healthcare Sector #279
Overall #1746
Revenue Y/Y Growth Statistics
High Average Low
87.04 % 4.83 % -55.46 %
(March 31, 2014)   (June 30. 2016)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Baxter International Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
392.5 % 4.29 % -80.25 %
(Mar 31 2025)  


BAX's I. Quarter Q/Q Revenue Comment
Baxter International Inc achieved in the I. Quarter 2025 above company average sequential Revenue doubling of 392.5%, to $ 2,625.00 millions, from $533.00 millions in the fourth quarter.
Baxter International Inc is impressively improving, not only reporting better then average increase, and additionally increasing speed.

Within Medical Equipment & Supplies industry Baxter International Inc achieved highest sequential Revenue growth. While Baxter International Inc 's Revenue growth quarter on quarter, overall rank is 31.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #16
Overall #31
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #16
Overall #31
Revenue Q/Q Growth Statistics
High Average Low
392.5 % 4.29 % -80.25 %
(Mar 31 2025)  


BAX's I. Quarter Q/Q Revenue Comment
Baxter International Inc achieved in the I. Quarter 2025 above company average sequential Revenue doubling of 392.5%, to $ 2,625.00 millions, from $533.00 millions in the fourth quarter.
Baxter International Inc is undergoing a remarkable growth, with reporting better then average growth, and also improving rate,Most analysts said.

Within Medical Equipment & Supplies industry Baxter International Inc achieved highest sequential Revenue growth. While Baxter International Inc 's Revenue growth quarter on quarter, overall rank is 31.


Baxter International Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2025)
12 Months Ending
(Dec 31 2024)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
Cumulative Revenue 12 Months Ending $ 9,669.00 $ 10,636.00 $ 13,852.00 $ 14,861.00 $ 14,756.00
Y / Y Revenue Growth (TTM) -34.47 % -28.2 % -7.35 % -1.03 % -1.99 %
Year on Year Revenue Growth Overall Ranking # 1860 # 1123 # 1556 # 870 # 290
Seqeuential Revenue Change (TTM) -9.09 % -23.22 % -6.79 % 0.71 % -0.38 %
Seq. Revenue Growth (TTM) Overall Ranking # 1746 # 1057 # 1705 # 1234 # 674


Cumulative Revenue growth Comment
Baxter International Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -34.47% year on year, at Mar 31 2025 compare to the -28.2% decrease at Dec 31 2024. If the Baxter International Inc 's fiscal year would end at Mar 31 2025, annual Revenue would be $9,669 millions.

In the Healthcare sector 288 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1123 to 1860.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 84
Healthcare Sector # 289
Overall # 1860

Revenue TTM Y/Y Growth Statistics
High Average Low
87.04 %
4.83 %
-55.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 84
Sector # 279
S&P 500 # 1746
Cumulative Revenue growth Comment
Baxter International Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -34.47% year on year, at Mar 31 2025 compare to the -28.2% decrease at Dec 31 2024. If the Baxter International Inc 's fiscal year would end at Mar 31 2025, annual Revenue would be $9,669 millions.

In the Healthcare sector 288 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1123 to 1860.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 84
Healthcare Sector # 289
Overall # 1860

Revenue TTM Y/Y Growth Statistics
High Average Low
87.04 %
4.83 %
-55.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 84
Sector # 279
S&P 500 # 1746




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BAX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BAX's Competitors
Revenue Growth for Baxter International Inc 's Suppliers
Revenue Growth for BAX's Customers

You may also want to know
BAX's Annual Growth Rates BAX's Profitability Ratios BAX's Asset Turnover Ratio BAX's Dividend Growth
BAX's Roe BAX's Valuation Ratios BAX's Financial Strength Ratios BAX's Dividend Payout Ratio
BAX's Roa BAX's Inventory Turnover Ratio BAX's Growth Rates BAX's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2025
Carlisle Companies Incorporated-0.06%$ -0.064 millions
Henry Schein Inc -0.13%$ -0.126 millions
Tactile Systems Technology Inc -0.14%$ -0.137 millions
Alpha Pro Tech Ltd -0.19%$ -0.186 millions
Gilead Sciences Inc -0.28%$ -0.284 millions
Jazz Pharmaceuticals Plc-0.46%$ -0.459 millions
Milestone Scientific Inc -0.73%$ -0.730 millions
Amphastar Pharmaceuticals Inc -0.76%$ -0.761 millions
Enhabit Inc -0.95%$ -0.953 millions
Elanco Animal Health Incorporated-1.00%$ -0.996 millions
Envista Holdings Corporation-1.17%$ -1.171 millions
Globus Medical Inc -1.41%$ -1.409 millions
Merck and Co Inc -1.56%$ -1.559 millions
Icad Inc-1.61%$ -1.615 millions
Fortrea Holdings Inc -1.63%$ -1.631 millions
Align Technology inc -1.78%$ -1.776 millions
Adapthealth Corp -1.84%$ -1.844 millions
Sunlink Health Systems Inc -2.05%$ -2.050 millions
Tonix Pharmaceuticals Holding Corp -2.14%$ -2.135 millions
Alpha Teknova Inc -2.19%$ -2.194 millions
Quidelortho Corp-2.56%$ -2.560 millions
Teladoc Health Inc -2.59%$ -2.594 millions
Tenet Healthcare Corp-2.70%$ -2.701 millions
Charles River Laboratories International inc -2.71%$ -2.708 millions
Scientific Industries Inc -3.10%$ -3.100 millions
Caribou Biosciences Inc -3.13%$ -3.129 millions
Apellis Pharmaceuticals Inc -3.21%$ -3.208 millions
Illumina Inc -3.25%$ -3.253 millions
Myriad Genetics Inc -3.46%$ -3.462 millions
Iridex Corp-3.52%$ -3.517 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com